French company DNA Script will contribute its enzymatic DNA synthesis technologies, while Quantoom of Belgium will bring its ...

While some of the initial zeal around localized vaccine production in Africa has waned since the height of the COVID-19 pandemic, efforts to bolster the continent’s immunization autonomy—especially | ...

From being a promising yet underexplored approach in the 1990s, mRNA therapeutics have evolved dramatically. The discovery of ...

Africa’s EVA Pharma, France’s DNA Script, and Belgium’s Quantoom Biosciences have signed a Memorandum of Understanding which ...

"This is a reliable and efficient foundation for mRNA synthesis that also delivers higher purity without host cell protein, gDNA, or endotoxin. We are delivering on our mission is to be the engine of ...

Genethon & Eukarÿs enter strategic partnership to develop a breakthrough technology to reduce the biomanufacturing cost of gene therapies: Evry, France Friday, January 24, 2025, ...

A novel microscopy method has been created by researchers from the Tanenbaum group at the Hubrecht Institute to view the ...

Justin Barbosa, GM and Vice President of TriLink Discovery, added “By integrating Molecular Assemblies technology into ...

“This is a reliable and efficient foundation for mRNA synthesis that also delivers higher purity without host cell protein, gDNA, or endotoxin. We are delivering on our mission is to be the ...

Eukarÿs has developed an engineered enzyme, C3P3, which significantly increases the production capacity of cells used for biopharmaceutical synthesis, by enhancing their mRNA synthesis capabilities.